Syngene International

Syngene International

SYNGENE

 ₹ 760.40
 ₹ 28.40
3.87%
Market Sentiment
TimelineReturnsVolume
Daily--
Weekly-5,57,276
Monthly13.42%1,05,95,912
Performance
TimelineDailyWeeklyMonthly
SYNGENE--13.42%
Index--0.68%
Peer Avg.--14.94%
*Avg of index constituents
Fundamentals
TimelinePEPBEV/EBIDTAROEROCEDiv. Yield
SYNGENE60.607.4628.0113.2713.210.16
Index35.445.9816.8116.9918.411.19
Peer Avg.101.216.2722.639.3210.210.25
*Avg of index constituents
Key Metrics
MetricsSales GrowthProfit GrowthROEROCE
FY '21-2219.29%-2.35%13.2713.21
FY '20-218.45%-1.82%16.5715.37
FY '19-2010.20%24.35%20.2119.59
Shareholding Pattern
PromotersFIIDIIPublicOthers
Promoters : 70.41%
FII : 13.67%
DII : 4.43%
Public : 11.49%
Others : 0%
Profit & Loss
MetricsSalesExpenditureEBITDAPAT
FY '21-222,602.801,863.65847.55394.80
FY '20-212,181.851,529.65735.50404.30
FY '19-202,011.901,409.10698.90411.80
All values are in crores
Peer Comparison
MetricsSalesExpenditureEBITDAPAT
SYNGENE2,602.801,863.65847.55394.80
LATENTVIEW307.29203.66124.74102.70
QUESS11,725.1411,319.44482.40198.75
All values are in crores

Similar Stocks

Apollo Hospitals Enterprise
 ₹ 6,428.05
- ₹ 61.80
-0.95%
Poly Medicure
 ₹ 1,554.90
- ₹ 5.10
-0.32%
Fortis Healthcare
 ₹ 434.80
 ₹ 1.00
0.23%
Max Healthcare Institute
 ₹ 873.60
 ₹ 9.25
1.07%
Narayana Hrudayalaya
 ₹ 1,319.00
 ₹ 5.95
0.45%
Dr. Lal Path Labs
 ₹ 2,370.45
 ₹ 66.15
2.87%
Thyrocare Technologies
 ₹ 626.35
 ₹ 4.30
0.69%
Aster DM Healthcare
 ₹ 488.20
 ₹ 12.95
2.72%
Metropolis Healthcare
 ₹ 1,885.40
 ₹ 84.70
4.70%

Syngene International Share Price

Syngene International Limited is an integrated research, development and manufacturing service company operating in India. The company provides contract research and manufacturing services from lead generation to clinical supply to pharmaceutical and biotechnology companies worldwide. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) production, formulation and analytical development, and clinical development services. It offers SynVent, a therapeutic discovery and development platform for drug development projects. SynVent's portfolio spans categories and therapeutic areas from small molecule inhibitors to targeted protein stabilisation. It serves the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries.

FAQs

Want to learn and earn in Stocks?